Q32 Bio (QTTB) Other Operating Expenses (2022)

Q32 Bio (QTTB) recorded quarterly Other Operating Expenses of $131.2 million in Q1 2022.

Q32 Bio (QTTB) Other Operating Expenses (2022) Analysis & Trends

Q32 Bio's Other Operating Expenses history runs 1 years deep, the most recent figure standing at $131.2 million for Q1 2022.

In Q1 2022, Other Operating Expenses changed N/A year-over-year to $131.2 million; the TTM figure through Dec 2022 stood at $131.2 million (changed N/A YoY), while the FY2025 annual figure was $11.7 million, changed N/A from the prior year.
Other Operating Expenses was $131.2 million for Q1 2022 at Q32 Bio.
In the past five years, Other Operating Expenses ranged from a high of $131.2 million in Q1 2022 to a low of $131.2 million in Q1 2022.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Q32 Bio	167.59 Mn	116.84 Mn	-

Historic Data

Download Data

Date	Value
Mar 31, 2022	131.25 Mn